Craneware Group Launches 340B Rebate Forum Ahead of 2026 Pilot Program
Craneware Group Launches 340B Rebate Forum Ahead of 2026 Pilot Program
On October 31, 2025, The Craneware Group held an important forum in Deerfield Beach, Florida, gathering leaders from 25 prominent U.S. health systems and representatives from Beacon/ESP and Apexus. The meeting focused on the preparations for the newly approved 340B Rebate Model Pilot Program by the Health Resources and Services Administration (HRSA).
A Significant Milestone
With the formal approval of eight manufacturer plans—including industry giants like Bristol Myers Squibb, AstraZeneca, and Merck—the 340B Rebate Model Pilot is set to launch on January 1, 2026. This marks a pivotal step in improving rebate processes for hospitals participating in the 340B drug discount program. As hospitals embark on a 60-day readiness period, which commenced on October 30, they are expected to finalize testing and adjustments within their systems.
Lidia Rodriguez-Hupp, Chief Customer Officer at The Craneware Group, emphasized the importance of this timeframe: "With HRSA's announcement, the clock has officially started. Over the next two months, hospitals and technology partners need to ensure their systems are equipped to handle the new rebates."
No New Vendor, No New Software
One of the most significant announcements from the forum was that The Craneware Group’s existing clients would not need to procure additional vendors or software to participate in the 340B Rebate Pilot. The functionalities required for this initiative are already integrated within their cloud-based Trisus® platform, ensuring that their operations remain seamless and efficient.
During the forum, participants were shown how the rebate functionalities would operate within Trisus®, which provides a comprehensive environment for charge capture, compliance, and financial analytics. "Our customers shouldn't have to chase compliance and 340B benefits through new vendors or disconnected systems," Rodriguez-Hupp added. "Trisus delivers the rebate workflow within the same environment hospitals already trust."
Key Operational Themes Under HRSA’s Pilot Framework
The forum outlined several important operational themes aligned with HRSA's framework for the pilot program:
- - Discount Priority: 340B rebates will be given precedence over Medicare Fair Price (MFP) in situations where both apply to the same dispense.
- - Continuity: A remarkable 95% of existing 340B processes will remain unchanged, with the pilot focusing on a small subset of high-spend National Drug Codes (NDCs).
- - Payment Timelines: Expected benchmarks for payment after rebate requests are set at 10 days for 340B rebates and 14 days for MFP.
- - Integration: For pilot NDCs, claims will flow through the Beacon system while The Craneware Group manages the necessary workflows, reconciliation, and transparency within the Trisus® platform.
Looking Forward
As the healthcare industry gears up for this transformative phase, hospitals and covered entities are encouraged to take full advantage of the 60-day readiness window. This final opportunity is critical for configuring systems, testing layouts, and validating eligibility ahead of the pilot’s start date.
Live demonstrations of The Craneware Group’s 340B rebate workflow are available for schedule, along with upcoming readiness webinars that provide further insights into maximizing participation in this innovative program.
About The Craneware Group
For over 25 years, The Craneware Group (AIMCRW.L) has been a trusted partner to more than 2,500 hospitals and health systems across the United States. Through its Trisus® cloud-based platform, the company consolidates clinical, financial, and operational data to enhance performance, compliance, and sustainability in healthcare services. With numerous Best in KLAS® awards and a strong presence on Microsoft Azure Marketplace, The Craneware Group is redefining the landscape of healthcare finance and administration.
For more information, visit The Craneware Group's website or follow them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.